GlaxoSmithKline
GSK's TYKERB Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer
Published in Cancer Law Weekly, February 20th, 2010
TYKERB is now indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the HER2 receptor for whom hormonal therapy is indicated. TYKERB in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2010-02-20)
More Articles from Cancer Law Weekly
- Asbestos Disease Awareness Organization ADAO
Sixth Annual International Asbestos Awareness Conference: April 9 - 11, Chicago - Biomoda, Inc.
Biomoda President to Testify on Bill Funding Lung Cancer Screening for Nebraska Veterans - Guided Therapeutics, Inc.
Guided Therapeutics, Inc. Receives New Funding Commitment from Konica Minolta Opto, Inc. to Expand Cancer Detection Product Line - Health Discovery Corporation
Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment - IP Advocate
In Wake of State of the Union Address, How Can Washington Help Small Businesses Thrive? Protect Their Patents, Says Inventor and IP Advocate Founder Dr. Renee Kaswan - Pharmaceutical Research and Manufacturers of America
'Sharing Miracles' Television Program to Feature Professional Basketball Legend Alonzo Mourning - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
